Furthermore, in NSCLC, EPIC1 stimulates vascular endothelial cell proliferation via the Ang2/Tie2 axis, resulting in angiogenesis and channel formation (Hou et al., 2021). This evidence concerns the gene TEK and non-small cell lung carcinoma.